A bipartisan group of senators introduced a bill in early August to clarify requirements, increase oversight, and reform the payment and data infrastructure of the 340B Drug Pricing Program. Read More »
In a recent letter, HHS called on the Office of Inspector General (OIG) to examine healthcare organizations’ billing of gender-affirming care provided to minors.Read More »
Hospitals could be facing lower reimbursement for non-drug items and services, 340B drugs, excepted off-campus provider-based department (PBD) services, as well as additional price transparency and prior authorization requirements, according to CMS’ 2027 Outpatient Prospective Payment System (...Read More »
The Office of Inspector General (OIG) recently conducted an audit to identify potential vulnerabilities in the Medicare program that could be contributing to improper payments for virtual check-in and e-visit services. Read More »
